Succimer Therapy
Succimer Therapy is a chelation-based antidote therapy that employs oral dimercaptosuccinic acid (succimer) to treat lead and other toxic heavy metal poisonings by selectively forming water-soluble metal–chelate complexes that enhance urinary excretion with minimal loss of essential trace elements.
49
Publications
2.3K
Citations
152
Authors
74
Institutions
Publications per year
2017–2026
0
Variants
Dimercaptosuccinic Acid TherapyDmsa Therapy
Parents
49
JN Gordon, Alan Taylor, Peter N. Bennett · British Journal of Clinical Pharmacology · 2002 · 121 citations · Full text
1–5 of 49
152
8
h-index
National Institute of Environmental Health Sciences, United States
6 publications · 624 citations
6
h-index
4
h-index
Rutgers, The State University of New Jersey, United States
4 publications · 585 citations
4
h-index
4
h-index
1–5 of 152
74
University of California, Santa Cruz
Santa Cruz, United States
7 h-index
7 publications
254 citations
National Institute of Environmental Health Sciences
Durham, United States
5 h-index
5 publications
610 citations
Harvard University
Cambridge, United States
5 h-index
5 publications
600 citations

Centers for Disease Control and Prevention
Atlanta, United States
4 h-index
4 publications
288 citations

University of Cincinnati Medical Center
Cincinnati, United States
4 h-index
4 publications
272 citations

Cornell University
Ithaca, United States
4 h-index
4 publications
158 citations

Children's Hospital of Philadelphia
Philadelphia, United States
3 h-index
3 publications
583 citations
Environmental and Occupational Health Sciences Institute
Piscataway, United States
3 h-index
3 publications
571 citations
1–8 of 74
5 publications · 167 citations
5
h-index
EHP · 5 publications · 137 citations
5
h-index
Repository · 4 publications · 120 citations
4
h-index
2 publications · 75 citations
2
h-index
TAAP · 2 publications · 72 citations
2
h-index
1–5